These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37898840)

  • 21. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
    Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION.
    Gasparini-Junior JL; Fanelli MF; Abdallah EA; Chinen LTD
    Arq Bras Cir Dig; 2019; 32(2):e1433. PubMed ID: 31038558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
    Rothé F; Maetens M; Rouas G; Paesmans M; Van den Eynde M; Van Laethem JL; Vergauwe P; Deboever G; Bareche Y; Vandeputte C; Ignatiadis M; Hendlisz A
    BMC Cancer; 2019 Apr; 19(1):304. PubMed ID: 30943928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer.
    Belderbos BPS; Sieuwerts AM; Hoop EO; Mostert B; Kraan J; Hamberg P; Van MN; Beaufort CM; Onstenk W; van Soest RJ; Martens J; Sleijfer S; de Wit R; Mathijssen RHJ; Lolkema MP
    Eur J Cancer; 2019 Nov; 121():48-54. PubMed ID: 31542641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of CTCs and CSCs in the staging and metastasis of non-small cell lung cancer based on microfluidic chip and the diagnostic significance.
    Wang SQ; Shuai ZF; Zhang XJ; Wu T; Dong HY; Liu T; Wen QT; Yu XW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9487-9496. PubMed ID: 33015791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
    Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
    Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study.
    Zapatero A; Gómez-Caamaño A; Cabeza Rodriguez MÁ; Muinelo-Romay L; Martin de Vidales C; Abalo A; Calvo Crespo P; Leon Mateos L; Olivier C; Vega Piris LV
    Radiat Oncol; 2020 Jun; 15(1):137. PubMed ID: 32487218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC).
    Melero JT; Ortega FG; Gonzalez AM; Carmona-Saez P; Garcia Puche JL; Sugarbaker PH; Delgado M; Lorente JA; Serrano MJ
    Surgery; 2016 Mar; 159(3):728-35. PubMed ID: 26518392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.
    Lorente D; Olmos D; Mateo J; Dolling D; Bianchini D; Seed G; Flohr P; Crespo M; Figueiredo I; Miranda S; Scher HI; Terstappen LWMM; de Bono JS
    Ann Oncol; 2018 Jul; 29(7):1554-1560. PubMed ID: 29741566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
    Lucci A; Hall CS; Patel SP; Narendran B; Bauldry JB; Royal RE; Karhade M; Upshaw JR; Wargo JA; Glitza IC; Wong MKK; Amaria RN; Tawbi HA; Diab A; Davies MA; Gershenwald JE; Lee JE; Hwu P; Ross MI
    Clin Cancer Res; 2020 Apr; 26(8):1886-1895. PubMed ID: 32015020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients.
    Molloy TJ; Bosma AJ; Baumbusch LO; Synnestvedt M; Borgen E; Russnes HG; Schlichting E; van't Veer LJ; Naume B
    Breast Cancer Res; 2011 Jun; 13(3):R61. PubMed ID: 21672237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
    Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.